← The Wire
SVRANasdaq
Savara Inc
Pharmaceutical Preparations · DE · CIK 1160308
Savara Inc develops and commercializes therapies for rare respiratory diseases
red 8-K · 90d
$1.08B
Market cap
$6.03
Last close
+2.2%
1D
+6.0%
5D
1.5M
Volume
Price · last 39 sessions+13.8%
May 4L $4.72 · H $6.03Jun 29
467
Total filings
Jun 8, 2026
Last filing
12/31
Fiscal year end
8-KExecutive Change · Bylaw AmendmentJun 8, 202610-Q10-QMay 12, 2026DEFA14ADEFA14AApr 24, 2026DEF 14ADEF 14AApr 24, 20268-KMaterial AgreementMar 13, 202610-K10-KMar 13, 20268-KMaterial Agreement · New Debt / ObligationJan 27, 20268-KReg FD DisclosureJan 9, 202610-Q10-QNov 12, 2025424B5424B5Oct 30, 20258-KMaterial Agreement · Company UpdateOct 30, 2025424B5424B5Oct 29, 20258-KMaterial Agreement · Reg FD DisclosureOct 29, 20258-KReg FD DisclosureSep 2, 202510-Q10-QAug 13, 20258-KShareholder VoteJun 6, 20258-KCompany UpdateMay 27, 202510-Q10-QMay 13, 2025DEFA14ADEFA14AApr 25, 2025DEF 14ADEF 14AApr 25, 202510-K/A10-K/AApr 25, 20258-KAgreement TerminatedMar 31, 202510-K10-KMar 27, 20258-KMaterial Agreement · Agreement TerminatedMar 26, 20258-KExecutive ChangeJan 23, 20258-KReg FD DisclosureJan 13, 2025SC 13GSC 13GNov 27, 202410-Q10-QNov 12, 2024SC 13GSC 13GNov 8, 2024SC 13GSEC SCHEDULE 13GNov 8, 2024SC 13GSC 13GOct 24, 202410-Q10-QAug 12, 20248-KMaterial Agreement · Company UpdateJun 28, 2024424B5424B5Jun 28, 20248-KReg FD Disclosure · Company UpdateJun 26, 20248-K/AExecutive ChangeJun 10, 20248-KBylaw Amendment · Shareholder VoteJun 7, 202410-Q10-QMay 9, 2024DEFA14ADEFA14AApr 26, 2024DEF 14ADEF 14AApr 26, 20248-KExecutive Change · Material AgreementApr 12, 202410-K10-KMar 7, 20248-KMaterial AgreementFeb 16, 2024SC 13GSC 13GFeb 8, 2024SC 13GSC 13GJan 31, 20248-KExecutive ChangeJan 25, 20248-KReg FD DisclosureJan 5, 202410-Q10-QNov 9, 202310-Q10-QAug 10, 2023SC 13GSC 13GJul 25, 20238-KMaterial Agreement · Company UpdateJul 13, 2023424B5424B5Jul 13, 20238-KShareholder VoteJun 9, 20238-KReg FD DisclosureJun 8, 202310-Q10-QMay 15, 2023DEFA14ADEFA14AApr 28, 2023DEF 14ADEF 14AApr 28, 20238-KBylaw AmendmentMar 30, 202310-K10-KMar 30, 20238-KReg FD DisclosureMar 10, 20238-KMaterial AgreementMar 2, 20238-KExecutive ChangeFeb 14, 20238-KExecutive ChangeDec 15, 202210-Q10-QNov 10, 20228-KExecutive ChangeAug 26, 202210-Q10-QAug 11, 20228-KShareholder VoteJun 3, 202210-Q10-QMay 11, 20228-KMaterial Agreement · New Debt / ObligationApr 22, 2022DEFA14ADEFA14AApr 19, 2022DEF 14ADEF 14AApr 19, 202210-K10-KMar 30, 20228-KExecutive ChangeJan 13, 20228-KReg FD DisclosureJan 10, 202210-Q10-QNov 12, 202110-Q10-QAug 12, 20218-KMaterial Agreement · Agreement TerminatedJul 7, 20218-KReg FD DisclosureJun 30, 20218-KBylaw Amendment · Shareholder VoteJun 14, 20218-KMaterial AgreementJun 4, 2021
Insider Activity
In the 90 days to Dec 19, 2025: 1 sold $121K.
| Date | Insider | Action | Shares | Price | Value |
|---|---|---|---|---|---|
| Dec 19, 2025 | Ramsay David ADirector | Sell | 20,000 | $6.06 | $121K |
Open-market buys & sells (Form 4, transaction codes P/S). Source: SEC structured insider data.
Similar companies
Comparable business profile · signals at a glance